Latest Insider Transactions at Prothena Corp Public LTD CO (PRTA)
This section provides a real-time view of insider transactions for Prothena Corp Public LTD CO (PRTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROTHENA CORP PUBLIC LTD CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROTHENA CORP PUBLIC LTD CO's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 12
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-41.12%
|
$300,000
$60.14 P/Share
|
Dec 12
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
Dec 05
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-27.15%
|
$310,000
$62.59 P/Share
|
Dec 05
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
Dec 01
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,834
-78.58%
|
$965,874
$61.7 P/Share
|
Dec 01
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,834
+49.62%
|
$95,004
$6.41 P/Share
|
Dec 01
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$248,000
$62.51 P/Share
|
Dec 01
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
Nov 30
2022
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-47.79%
|
$310,000
$62.96 P/Share
|
Nov 30
2022
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
Nov 23
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-37.32%
|
$610,000
$61.36 P/Share
|
Nov 23
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
Nov 18
2022
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-98.87%
|
$570,000
$57.66 P/Share
|
Nov 18
2022
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$150,000
$15.04 P/Share
|
Nov 10
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-62.22%
|
$275,000
$55.73 P/Share
|
Nov 10
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
Nov 07
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-40.36%
|
$275,000
$55.78 P/Share
|
Nov 07
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
Nov 01
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-93.61%
|
$248,000
$62.12 P/Share
|
Nov 01
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
Nov 01
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,833
-58.09%
|
$997,479
$63.53 P/Share
|
Nov 01
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,833
+49.62%
|
$94,998
$6.41 P/Share
|
Oct 27
2022
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$1,240,000
$62.0 P/Share
|
Oct 27
2022
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$200,000
$10.27 P/Share
|
Oct 26
2022
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
65,000
-61.39%
|
$3,900,000
$60.25 P/Share
|
Oct 26
2022
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
65,000
+50.0%
|
$650,000
$10.27 P/Share
|
Oct 24
2022
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
20,000
-68.77%
|
$1,140,000
$57.74 P/Share
|
Oct 24
2022
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$300,000
$15.04 P/Share
|
Oct 19
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-26.9%
|
$560,000
$56.7 P/Share
|
Oct 19
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
Oct 10
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
5,000
-73.24%
|
$275,000
$55.88 P/Share
|
Oct 10
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.41 P/Share
|
Oct 05
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
5,000
-29.74%
|
$290,000
$58.35 P/Share
|
Oct 05
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+44.57%
|
$30,000
$6.41 P/Share
|
Oct 03
2022
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$240,000
$60.9 P/Share
|
Oct 03
2022
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$96,000
$24.9 P/Share
|
Oct 03
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
15,833
-54.99%
|
$965,813
$61.61 P/Share
|
Oct 03
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
15,833
+49.62%
|
$94,998
$6.41 P/Share
|
Sep 28
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
16,412
-7.47%
|
$869,836
$53.72 P/Share
|
Sep 28
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,412
+35.98%
|
$98,472
$6.41 P/Share
|
Sep 28
2022
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
31,666
-99.24%
|
$1,519,968
$48.09 P/Share
|
Sep 28
2022
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
31,666
+49.81%
|
$189,996
$6.41 P/Share
|
Sep 28
2022
|
Shane Cooke |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$480,000
$48.09 P/Share
|
Sep 28
2022
|
Shane Cooke |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$60,000
$6.41 P/Share
|
Sep 28
2022
|
Richard T Collier |
SELL
Open market or private sale
|
Direct |
25,000
-95.35%
|
$1,200,000
$48.09 P/Share
|
Sep 28
2022
|
Richard T Collier |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+48.81%
|
$150,000
$6.41 P/Share
|
Sep 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
10,000
-75.76%
|
$300,000
$30.75 P/Share
|
Sep 21
2022
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+43.1%
|
$60,000
$6.73 P/Share
|
Sep 21
2022
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
2,720
-17.53%
|
$87,040
$32.02 P/Share
|
Sep 21
2022
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,720
+14.92%
|
$16,320
$6.41 P/Share
|